Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine Tumors
Despite LN-negative status, a subset of patients with PanNETs remained at high risk for recurrence. This validated risk score stratifies recurrence and survival risk showing biological relevance. These findings provide a framework for refining postoperative surveillance and risk-adapted therapeutic strategies.
Authors
- Alice C. Wei (ORCID: https://orcid.org/0000-0002-2505-959X)
- Arsen Osipov (ORCID: https://orcid.org/0000-0002-9000-7040)
- Marco Ventin (ORCID: https://orcid.org/0000-0002-4201-7009)
- Kambiz Kosari (ORCID: https://orcid.org/0000-0002-2631-4054)
- Francesco Sabbatino (ORCID: https://orcid.org/0000-0001-6431-8278)
- Andrew Hendifar (ORCID: https://orcid.org/0000-0002-2079-9177)
- Motaz Qadan (ORCID: https://orcid.org/0000-0001-6951-8308)
- Luigi Liguori (ORCID: https://orcid.org/0000-0002-0232-1452)
- Keith D. Lillemoe (ORCID: https://orcid.org/0009-0004-5057-3875)
- Giulia Cattaneo (ORCID: https://orcid.org/0000-0002-7053-3238)
- Amer H. Zureikat (ORCID: https://orcid.org/0000-0002-7800-5464)
- Carlos Fernandez del-Castillo
- Jing He (ORCID: https://orcid.org/0000-0002-1954-2892)
- Shahrzad Arya (ORCID: https://orcid.org/0009-0002-2451-7584)
- Cristina R. Ferrone (ORCID: https://orcid.org/0000-0002-9465-7008)
- Nicholas N. Nissen (ORCID: https://orcid.org/0009-0003-1078-091X)
- Alexandra Gangi
Institutions
- Cedars-Sinai Medical Center (US)
- University of Salerno (IT)
- Memorial Sloan Kettering Cancer Center (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- University of Pittsburgh Medical Center (US)
- Johns Hopkins Hospital (US)
Publication Details
- Journal
- JAMA Surgery
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1001/jamasurg.2025.5401
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 1.35